BioNTech schließt Übernahme von Neon Therapeutics ab
06 mai 2020 16h15 HE
|
BioNTech SE
MAINZ, Deutschland und CAMBRIDGE, USA, May 06, 2020 (GLOBE NEWSWIRE) -- BioNTech (Nasdaq: BNTX, “BioNTech” oder „das Unternehmen”) gab heute den Abschluss der Übernahme von Neon Therapeutics, Inc....
BioNTech Completes Acquisition of Neon Therapeutics
06 mai 2020 16h15 HE
|
BioNTech SE
MAINZ, Germany and CAMBRIDGE, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- BioNTech (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the closing of the Neon Therapeutics, Inc. (Nasdaq: NTGN,...
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
16 janv. 2020 07h30 HE
|
BioNTech SE; Neon Therapeutics, Inc.
Further expands BioNTech’s growing CAR-T and TCR therapy pipeline through addition of neoantigen specific cell therapies, including a T cell therapy targeting shared RAS oncogenesAccelerates...